多元化医疗信托2025年季度报告

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC20549 FORM10-Q DIVERSIFIED HEALTHCARE TRUST (Exact Name of Registrant as Specified in Its Charter) Indicate by check mark whether the registrant:(1)has filed all reports required to be filed by Section13 or 15(d)of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filing Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or anemerging growth company.See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new orrevised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act).Yes☐No☒ Number of registrant's common shares outstanding as of April 30, 2025:241,250,885 PARTIFinancial InformationItem 1.Financial Statements (unaudited)1Condensed Consolidated Balance Sheets —March31, 2025and December31, 20241Condensed Consolidated Statements of Comprehensive Income (Loss) — ThreeMonths EndedMarch31, 2025and 20242Condensed Consolidated Statements of Shareholders' Equity — ThreeMonths EndedMarch31, 2025and 20243Condensed Consolidated Statements of Cash Flows — Three Months Ended March 31, 2025 and 20244Notes to Condensed Consolidated Financial Statements6Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations21Item 3.Quantitative and Qualitative Disclosures About Market Risk37Item 4.Controls and Procedures38Warning Concerning Forward-Looking Statements39Statement Concerning Limited Liability41PARTIIOther Information42Item1A.Risk Factors42Item 2.Unregistered Sales of Equity Securities and Use of Proceeds42Item 6.Exhibits42Signatures45 References in this Quarterly Report on Form10-Q to the Company, we, us or our include Diversified Healthcare Trust and its consolidatedsubsidiaries unless otherwise expressly stated or the context indicates otherwise. DIVERSIFIED HEALTHCARE TRUSTCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)(dollars in thousands)(unaudited) (1)Includes $34,700of accreted interest paid during the three months ended March31, 2025 on our senior secured notes due 2026. Supplemental disclosure of cash and cash equivalents and restricted cash: The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within our condensed consolidatedbalance sheets to the amount shown in our condensed consolidated statements of cash flows: (1)Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties. The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. Table of Contents DIVERSIFIED HEALTHCARE TRUSTNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) Note 1.Basis of Presentation The accompanying condensed consolidated financial statements of Diversified Healthcare Trust and its subsidiaries, or DHC, we, us, orour, are unaudited.Certain information and disclosures required by U.S. generally accepted accounting principles, or GAAP, for completefinancial statements have been condensed or omitted.We believe the disclosures made are adequate to make the information presented notmisleading.However, the accompanying condensed consolidated financial statements should be read in conjunction with the consolidated In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of resultsfor the interim period have been included. All intercompany transactions and balances with or among our consolidated subsidiaries have been The preparation of these financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reportedamounts. Actual results could differ from those estimates.Significant estimates in our condensed consolidated financial statements include We have been, are currently, and expect in the future to be involved in claims, lawsuits, and regulatory and other governmental audits,investigations and proceedings arising in the ordinary course of our business. While the outcome of any litigation is inherently uncertain, we do Note 2.Recen